18th Conference on Retroviruses and Opportunistic Infections (CROI) 27 February-–3 March 2011, Boston

1 August 2011. Related: Conference reports, Conference index, CROI 18 (Retrovirus) 2011.

Introduction

Our final reports from this important conference are:

• Monitoring treatment in resource limited settings: results from PHPT-3 and Stratall ANRS12110/ESTER trials

• DART: high rates of viral suppression after five years and a single CD4 test with a threshold of 250 cells/mm3 could reduce unnecessary switching

• Lopinavir/r monotherapy used as second-line therapy in resource-limited settings

• Treating children previously exposed to single dose nevirapine: update on IMPAACT P1060 and NEVEREST

• Lopinavir/ritonavir oral solution toxicity in neonates

• Paediatric antiretroviral pipeline: darunavir and raltegravir

• Pharmacokinetics of different rifabutin dosing strategies with lopinavir/ritonavir-based ART

• Initiation of ART during breastfeeding can induce multidrug resistance in infants

Unless mentioned otherwise, all references are to the Programme and Abstracts of the 18th Conference on Retroviruses and Opportunistic Infections, 28 February–2 March 2011, Boston.

http://www.retroconference.org/AbstractSearch/

Webcasts are available at the following link:

http://www.retroconference.org/2011/data/files/webcast_2011.htm